MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 81 filers reported holding MIRATI THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.12 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $52,000 | +67.7% | 400 | 0.0% | 0.02% | +69.2% |
Q3 2019 | $31,000 | -24.4% | 400 | 0.0% | 0.01% | -27.8% |
Q2 2019 | $41,000 | +41.4% | 400 | 0.0% | 0.02% | +50.0% |
Q1 2019 | $29,000 | +70.6% | 400 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $17,000 | -10.5% | 400 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $19,000 | -40.6% | 400 | -38.5% | 0.01% | -38.5% |
Q2 2018 | $32,000 | +60.0% | 650 | 0.0% | 0.01% | +44.4% |
Q1 2018 | $20,000 | -13.0% | 650 | -48.0% | 0.01% | 0.0% |
Q4 2017 | $23,000 | +91.7% | 1,250 | +25.0% | 0.01% | +80.0% |
Q3 2017 | $12,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |